Nguyen H. Tran

PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors

Susan N. Payne, Molly E. Maher, Nguyen H. Tran et al. · Oncogenesis · 2015 · 71 citations · Full text

PGE2 and LTB4 tissue levels in benign and cancerous prostates

S. Larré, Nguyen H. Tran, Cheng Fan et al. · Prostaglandins & Other Lipid Mediators · 2008 · 51 citations

Urology, Translational Biology, Genitourinary Cancer +6

PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga

Scott M. Thompson, Garima Suman, Michael Torbenson et al. · Hepatology Communications · 2021 · 45 citations · Full text

Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer

Nguyen H. Tran, Vaibhav Sahai, Kent A. Griffith et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 37 citations · Full text

Surgical Oncology, Radiation Medicine, Pancreatic Cancer +9

A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma

Daniel H. Ahn, Pedro Luiz Serrano Usón, Peter Masci et al. · Investigational New Drugs · 2021 · 27 citations

Surgical Oncology, Oncology, Medicine +9